Inhibitory role of TRIP-Br1 oncoprotein in anticancer drug-mediated programmed cell death via mitophagy activation

Chemotherapy has been widely used as a clinical treatment for cancer over the years. However, its effectiveness is limited because of resistance of cancer cells to programmed cell death (PCD) after treatment with anticancer drugs. To elucidate the resistance mechanism, we initially focused on cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Samil, Myagmarjav, Davaajargal, Jo, Taeyeon, Lee, Soonduk, Han, Songyi, Quynh, Nguyen Thi Ngoc, Anh, Nguyen Hai, Vu, Son Hai, Choi, Yeongseon, Lee, Myeong-Sok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254482/
https://www.ncbi.nlm.nih.gov/pubmed/35813469
http://dx.doi.org/10.7150/ijbs.72138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254482/
https://www.ncbi.nlm.nih.gov/pubmed/35813469
http://dx.doi.org/10.7150/ijbs.72138

Ejemplares similares